Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000069

President and CEO sold 1,000 shares at $15.00 ($15,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Doshi Dipal President and CEO 2023-10-17 Sale 10b5-1 −1,000 $15.00 $15,000 247,279 D
Open-market sales · 1,000 sh · avg $15.00 · $15,000
Loading xslF345X05/wk-form4_1697750861.xml…